ALC

Air Lease Corporation Announces Lease Placement of 18 New Boeing 737-8 Aircraft with EGYPTAIR

Retrieved on: 
Monday, November 13, 2023
Professional Services, Air, Transport, Aerospace, Manufacturing, Finance, ALC, Assistant, NYSE, Security (finance), Boeing 737 MAX, AIR, IATA, Air Lease Corporation, Friends, Star Alliance, Aircraft, Growth, EGYPTAIR, News, Airline, Boeing

DUBAI AIR SHOW – Today Air Lease Corporation (NYSE: AL) announced long-term lease contracts for 18 new Boeing 737-8 aircraft with EGYPTAIR.

Key Points: 
  • DUBAI AIR SHOW – Today Air Lease Corporation (NYSE: AL) announced long-term lease contracts for 18 new Boeing 737-8 aircraft with EGYPTAIR.
  • These new Boeing aircraft are confirmed to deliver to the airline beginning in 2025 through 2026 from ALC’s order book with Boeing.
  • “We are pleased to announce this deal for 18 new Boeing 737-8 aircraft with ALC’s new customer, EGYPTAIR, and be the first to lease the 737-8 to the airline,” said Steven F. Udvar-Hazy, Executive Chairman of Air Lease Corporation.
  • About Air Lease Corporation (NYSE: AL)
    Air Lease Corporation is a leading global aircraft leasing company based in Los Angeles, California that has airline customers throughout the world.

Air Lease Corporation Announces Delivery of First of Nine New Airbus A321-200neo Aircraft to ITA Airways

Retrieved on: 
Friday, November 10, 2023
Professional Services, Air, Transport, Aerospace, Manufacturing, Finance, ALC, NYSE, Security (finance), Air Lease Corporation, SkyTeam, Airbus A320neo family, Airbus A321, Airbus, Exercise, ITA Airways, Country, A220, Aircraft, Airbus A330neo, Airline, A350

Today Air Lease Corporation (NYSE: AL) announced one new Airbus A321-200neo aircraft delivered to ITA Airways.

Key Points: 
  • Today Air Lease Corporation (NYSE: AL) announced one new Airbus A321-200neo aircraft delivered to ITA Airways.
  • This aircraft is the first of nine new Airbus A321s confirmed to deliver to the Italian airline from ALC’s order book with Airbus in 2023 through 2025.
  • “ALC is pleased to announce this delivery of one new Airbus A321-200neo aircraft to ITA Airways and be the first to introduce the A321neo to the airline,” said Steven F. Udvar-Házy, Executive Chairman of Air Lease Corporation.
  • About Air Lease Corporation (NYSE: AL)
    Air Lease Corporation is a leading global aircraft leasing company based in Los Angeles, California that has airline customers throughout the world.

Experience The Thrill of Treasure Hunting With Yaysay: The AI-Powered Shopping App Redefining Retail

Retrieved on: 
Monday, December 11, 2023
Online, ALC, Gamify (company), Social shopping, Entrepreneurship, Fun, Ganni, System, Friends, Löwe, Gilt Groupe, Euphoria, AI, Acne, Online shopping, Amusement park, Vince

NEW YORK, Dec. 11, 2023 /PRNewswire/ -- Launching today out of Beta mode, Yaysay is a new feed-based, discovery-driven shopping app that elevates off-price shopping and gamifies the thrill of the hunt. Yaysay is brought to you by retail powerhouses from Casper, Gilt Groupe and Stitch Fix, with business mogul and bonafide deal hunter, Bethenny Frankel, serving as advisor.

Key Points: 
  • If you don't snag your favorites quickly — just like a swipe on a dating app — your fashion finds are gone forever.
  • "We wanted to create a mobile shopping experience that's fun, and feels like a little bite-sized treat at the touch of your fingertips.
  • We've utilized AI combined with a novel shopping experience to digitally recreate the unique off-price treasure hunt experience online for the first time."
  • Yaysay offers a novel and exciting shopping experience, replicating the real-life thrill of the hunt conveniently on your phone.

American Licorice Company Expands Giving Tuesday Efforts to Support Local Nonprofits

Retrieved on: 
Friday, December 8, 2023
ALC, Research, Student, Glycyrrhiza lepidota, Multimedia, Candy, The Rodale Institute, Meat, Mentorship, American Licorice Company, Bread, Partnership, Slicer, Loaf, Food, Management

LAPORTE, Ind., Dec. 7, 2023 /PRNewswire/ -- American Licorice Company (ALC) deepened their commitment to community on Giving Tuesday (Nov. 28), a national day for supporting nonprofit organizations.

Key Points: 
  • LAPORTE, Ind., Dec. 7, 2023 /PRNewswire/ -- American Licorice Company (ALC) deepened their commitment to community on Giving Tuesday (Nov. 28), a national day for supporting nonprofit organizations.
  • American Licorice has historically participated in Giving Tuesday by providing local nonprofit organizations with financial support.
  • We were joined by American Licorice Company, who helped to provide not only candy but packed boxes for our clients as well.
  • We are so thankful to American Licorice [for giving] back in so many ways to support our efforts to fight food insecurity."

MINERVA FOODS FILES EBITDA OF BRL 713,7 MILLION AND NET PROFIT OF BRL 141 MILLION IN 3Q23

Retrieved on: 
Wednesday, November 8, 2023
Ethos, Working capital, International, ESG, Meat, Integrity, EBITDA, Minerva, BPU, Acquisition, International Financial Reporting Standards, BRL, Cash flow, ALC, Net, Bookkeeping, Marfrig, Capital expenditure

BARRETOS, Brasil, Nov. 8, 2023 /PRNewswire/ -- Minerva Foods (Minerva S.A – B3: BEEF3 | OTC – Nasdaq International: MRVSY), a leader in the export of fresh beef and its derivatives in South America, and which also operates in the processed beef segment, reports its earnings for the third quarter of 2023. The following financial and operational information is presented in BRGAAP, in Reals (BRL), according to International Financial Reporting Standards.

Key Points: 
  • The following financial and operational information is presented in BRGAAP, in Reals (BRL), according to International Financial Reporting Standards.
  • EBITDA in the third quarter of 2023 totaled BRL 713,1 million and the EBITDA margin was 10,1%.
  • In the last twelve months ending in September, EBITDA was BRL 2,6 billion and the EBITDA margin was 9,3%.
  • Free Cash Flow in 3Q23, after Financial Expenses, Capex, and Working Capital, was BRL 608,1 million.

MINERVA FOODS FILES EBITDA OF BRL 713,7 MILLION AND NET PROFIT OF BRL 141 MILLION IN 3Q23

Retrieved on: 
Wednesday, November 8, 2023
Ethos, Working capital, International, ESG, Meat, Integrity, EBITDA, Minerva, BPU, Acquisition, International Financial Reporting Standards, BRL, Cash flow, ALC, Net, Bookkeeping, Marfrig, Capital expenditure

BARRETOS, Brasil, Nov. 8, 2023 /PRNewswire/ -- Minerva Foods (Minerva S.A – B3: BEEF3 | OTC – Nasdaq International: MRVSY), a leader in the export of fresh beef and its derivatives in South America, and which also operates in the processed beef segment, reports its earnings for the third quarter of 2023. The following financial and operational information is presented in BRGAAP, in Reals (BRL), according to International Financial Reporting Standards.

Key Points: 
  • The following financial and operational information is presented in BRGAAP, in Reals (BRL), according to International Financial Reporting Standards.
  • EBITDA in the third quarter of 2023 totaled BRL 713,1 million and the EBITDA margin was 10,1%.
  • In the last twelve months ending in September, EBITDA was BRL 2,6 billion and the EBITDA margin was 9,3%.
  • Free Cash Flow in 3Q23, after Financial Expenses, Capex, and Working Capital, was BRL 608,1 million.

Immutep Announces New Biomarker Data from TACTI-002 Phase II in First Line Non-Small Cell Lung Cancer

Retrieved on: 
Friday, November 3, 2023
ASX, MHC, PD-L1, NSCLC, Gamma ray, Poster, ESMO, Progression-free survival, Biomarker, TPS, RNA, Society for Immunotherapy of Cancer, Pembrolizumab, GEP, AIPAC, Merck, CD8, SITC, T cell, Immunotherapy, Paclitaxel, Immune system, Annual general meeting, ALC, Blood, Autoimmune disease, Serum, Gene, Lung cancer, CXCL10, Lymphocyte, IMM, Cancer, Society, Monocyte, Patient, Merck & Co., Vaccine, Medical imaging, Pharmaceutical industry, LAG-3

SYDNEY, AUSTRALIA, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces new biomarker data from the TACTI-002/KEYNOTE-798 Phase II trial evaluating eftilagimod alpha (“efti”), a soluble LAG-3 protein and first-in-class MHC Class II agonist administered subcutaneously, in combination with MSD’s (Merck & Co., Inc., Rahway, NJ., USA) anti-PD-1 therapy KEYTRUDA® (pembrolizumab) as first-line treatment for patients with previously untreated unresectable or metastatic non-small cell lung cancer (NSCLC).

Key Points: 
  • Dr Frederic Triebel, Immutep CSO, said, “Immunomonitoring of blood cells is of prime importance when one would like to understand the effect of a systemic immunostimulant injected subcutaneously, like efti is.
  • Importantly, the pharmacodynamic data from efti in combination with pembrolizumab is associated with the 35.5-month median Overall Survival in first-line treatment of metastastic non-small cell lung cancer patients expressing PD-L1 (TPS >1%) that we recently reported at ESMO 2023.
  • This biomarker data from the TACTI-002 Phase II is similar to the biomarker analysis from Immutep’s randomized, double-blind AIPAC Phase IIb trial in HER2-/HR+ metastatic breast cancer, which combined efti solely with paclitaxel chemotherapy and did not include any anti-PD-1 therapy.
  • The poster titled “Biomarker results from the 1st line non-small cell lung cancer cohort of TACTI-002: pharmacodynamic effects of combining eftilagimod alpha (soluble LAG-3) and pembrolizumab” will be available on the Posters & Publications section of Immutep’s website.

Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology

Retrieved on: 
Monday, November 6, 2023
Oncology, Health, Clinical Trials, Pharmaceutical, Cardiology, Biotechnology, EOS, Type, EULAR, Patient, Standard of care, Lupus nephritis, Itolizumab, III, EGFR, Therapy, AMP, Children's Organ Transplant Association, CD6, Infection, Society, American Society of Nephrology, European Alliance of Associations for Rheumatology, European Renal Association, Dialysis, ASN, Partnership, MMF, ORR, ALC, S1P, Ono Pharmaceutical, Safety, Serum albumin, Proteinuria, Pharmaceutical industry, Silviculture, Nursing, Lupus, UPCR

“The presentation at ASN represents current data from the EQUALISE study, which includes all but the last patient in the follow up period,” said Bruce Steel, chief executive officer at Equillium.

Key Points: 
  • “The presentation at ASN represents current data from the EQUALISE study, which includes all but the last patient in the follow up period,” said Bruce Steel, chief executive officer at Equillium.
  • “We are encouraged that we continue to see clinically meaningful response rates, particularly in these highly proteinuric subjects.
  • Results are comparable to those observed in the Phase 3 AURORA1 study of voclosporin (ORR 70% at 6 and 12 months in active treatment).
  • Consistent with the decline in UPCR overtime, subjects were able to taper their systemic corticosteroids over the course of the study.

Industry Icon Kraig Schwigen Joins American Lending Center to Guide Strategic Development

Retrieved on: 
Thursday, November 2, 2023
Finance, Law Enforcement, Emergency Services, Professional Services, Small Business, Public Policy, Government, Rock Island County, Illinois, Congress, Federal Bureau of Investigation, American Investment Council, Secret Service, Retirement, ALC, EB-5, CMB, Business, Video game

American Lending Center is pleased to announce that Kraig Schwigen has joined the firm as Vice President of Strategic Development.

Key Points: 
  • American Lending Center is pleased to announce that Kraig Schwigen has joined the firm as Vice President of Strategic Development.
  • “Kraig is one of the giants in our industry, especially when it comes to serving EB-5 investors,” said John Shen, president and CEO of American Lending Center (ALC).
  • We’re thrilled and blessed to have him join us.”
    From 1985 to 2008, Schwigen was a law enforcement officer with the Rock Island County, Illinois, Sheriff’s Department.
  • After his retirement from CMB, Schwigen and Steve Parnell launched American Investment Migration to create a platform for developers seeking EB-5 capital.

Air Lease Corporation Announces Lease Placement of Two New Boeing 737-8 Aircraft with LOT Polish Airlines

Retrieved on: 
Tuesday, October 31, 2023
Finance, Public Relations, Investor Relations, Communications, Professional Services, Air, Aerospace, Transport, Manufacturing, Air Lease Corporation, Security (finance), NYSE, LOT Polish Airlines, LOT, AL, Securities and Exchange Commission of Pakistan, Boeing 737 MAX, Boeing 787 Dreamliner, ALC, Boeing, Aircraft, Airline

Today, Air Lease Corporation (NYSE: AL) announced long-term lease placements for two new Boeing 737-8 aircraft with LOT Polish Airlines.

Key Points: 
  • Today, Air Lease Corporation (NYSE: AL) announced long-term lease placements for two new Boeing 737-8 aircraft with LOT Polish Airlines.
  • Both aircraft are scheduled to deliver to LOT in mid-2024, and will add to the 11 Boeing 737-8s and one 787-9 Dreamliner aircraft already on lease from ALC.
  • “We are pleased to further expand our long-term relationship with LOT by leasing the airline an additional two new 737-8 jet aircraft.
  • About Air Lease Corporation (NYSE: AL)
    Air Lease Corporation is a leading global aircraft leasing company based in Los Angeles, California that has airline customers throughout the world.